Investigators on the Path to Alzheimer’s Detection Test
A team from Brigham and Women’s Hospital are developing a test that can detect tau protein, a calling card for Alzheimer’s disease.
IVD
GRAIL’s SUMMIT Will Help Define its Liquid Biopsy Path
The Menlo Park, CA-based company’s 50,000-patient trial will launch in 2019 and could be one of the most significant events of the year for the liquid biopsy market.
How a New Blood Volume Analyzer Could Save Lives From Acute Heart Failure
Daxor’s new technology designed to measure blood volume has the potential to reduce patient readmission rates and improve outcomes for patients suffering from acute heart failure.
Diagnostics Are Helping Counter Antimicrobial Resistance, But More Work Is Needed
Doctors need more tools to quickly determine whether an antibiotic is truly needed, an expert tells MD+DI.
Oxford Startup Wants to Revolutionize Sensors
A startup spawned from Oxford University is trying to commercialize components of a quantum computing technology that could ultimately improve the downstream end of existing diagnostic devices.
New Blood Test Makes the Autism Picture a Bit Clearer
The Madison, WI-based company said its test can identify metabolic subtypes associated with the Autism Spectrum and can be used to screen children as young as 18 months.
New York State Initiative Hopes to Stop the Spread of Super Bugs
Diagnostics manufacturer OpGen is partnering with ILUM and the NY State Department of Health to detect, track, and manage antimicrobial-resistant infections at healthcare institutions statewide.
What Will Be Your Next Move in the In Vitro Diagnostic Space?
A panel of IVD experts will discuss the latest in vitro diagnostic trends at the BIOMEDevice San Jose conference in December.
Bringing Precision Diagnostics Home
New technologies in RNA analysis tests benefit autoimmune disease sufferers.
Abbott-Alere One Year Later: Was It Worth All the Fuss?
It's been a full year since Abbott closed its $5.3 billion acquisition of Alere, a deal that almost didn't happen.
MeMed Looks to Distinguish Between Bacterial and Viral Infections
The Haifa, Israel-based company has raised more than $70 million in a funding round.
Could a New Biosensor Be Able to Smell Cancer?
Aromyx Corp. announces its groundbreaking biosensor technology based on the human sense of smell and taste. The company says the new technology has the potential to be used as a diagnostic tool to detect early stage cancer and disease.
How a $2M Grant Could Change the Way Autism Is Diagnosed
Quadrant Biosciences scored a $2 million NIH grant to supports its epigenetic diagnostic test for autism spectrum disorder.
7 Key Events That Solidified the Liquid Biopsy Market
Seven key trends and events helped make Liquid Biopsy attractive to investors, shareholders, patients, and physicians.
Are You Really Ready For MDR?
Audrey Turley, of Nelson Labs, will speak at Medical Design & Manufacturing Minneapolis about biocompatibility issues related to medical devices including the move to more in vitro testing and the 2020 deadline for the new European Medical Device Regulation.
An Epic Approach Toward Liquid Biopsy
San Diego, CA-based Epic Sciences has raised nearly $52 million in a series E round.